Cue biopharma to present at the jefferies 2023 global healthcare conference

Boston, june 05, 2023 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific t cells directly within the patient's body, announced today that it will present at the jefferies global healthcare conference being held june 7–9, 2023 in new york.
CUE Ratings Summary
CUE Quant Ranking